{"ModuleTitle": "Company Description", "CompanyName": "Agenus Inc.", "Symbol": "AGEN", "Address": "3 FORBES ROAD, LEXINGTON, Massachusetts, 02421, United States of America", "Phone": "781-674-4410", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "We are a clinical-stage immuno-oncology (\"I-O\") company advancing an extensive\r\npipeline of immune checkpoint antibodies, adoptive cell therapies and neoantigen\r\ncancer vaccines, to fight cancer. Our business is designed to drive success in\r\nI-O through speed, innovation and effective combination therapies. We believe\r\nthat combination therapies and a deep understanding of each patient's cancer\r\nwill drive substantial expansion of the patient population benefiting from\r\ncurrent I-O therapies. In addition to a diverse pipeline, we have assembled\r\nfully integrated end-to-end capabilities including novel target discovery,\r\nantibody generation, cell line development and good manufacturing practice\r\n(\"GMP\") manufacturing. We believe that these fully integrated capabilities\r\nenable us to produce novel candidates on timelines that are shorter than the\r\nindustry standard. Leveraging from our science and capabilities, we have forged\r\nimportant partnerships to advance our innovation.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f16%2f0001564590-20-011221.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Anna Wijatyk", "title": "Vice President-Clinical Development"}, {"name": "Christine M. Klaskin", "title": "CFO, Chief Accounting Officer & VP-Finance"}, {"name": "Garo H. Armen", "title": "Chairman & Chief Executive Officer"}, {"name": "Jennifer Buell", "title": "President & Chief Operating Officer"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}